Tech Company Inital Public Offerings

Harmony Biosciences IPO

Harmony Biosciences, based in Plymouth Meeting, debuted as a public company on 8/18/2020.

Transaction Overview

Announced On
8/18/2020
Transaction Type
IPO
Amount
$127,200,000
Proceeds Purpose
Per the firm's most recent regulatory filing, it plans to use the net proceeds as follows:approximately $78.0 million to fund external clinical development for the potential new indications for pitolisant in PWS, MD and pediatric narcolepsy through clinical development; andthe remainder for working capital, business development opportunities, a potential milestone payment to Bioprojet and general corporate purposes, including to support the continued commercialization of WAKIX in the United States.

Company Information

Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
630 W Germantown Pike 220
Plymouth Meeting, PA 19462
USA
Phone
Undisclosed
Email Address
Overview
Harmony Biosciences (Nasdaq: HRMY) is an innovative biopharmaceutical company dedicated to identifying, developing, and commercializing novel treatment options for patients with rare diseases. With an emphasis on Central Nervous System (CNS) disorders, our goal is to push the boundaries of what science can do to improve the lives of patients.
Profile
Harmony Biosciences LinkedIn Company Profile
Social Media
Harmony Biosciences Company Twitter Account
Company News
Harmony Biosciences News
Facebook
Harmony Biosciences on Facebook
YouTube
Harmony Biosciences on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
John Jacobs
  John Jacobs LinkedIn Profile  John Jacobs Twitter Account  John Jacobs News  John Jacobs on Facebook
Chief Financial Officer
Susan Drexler
  Susan Drexler LinkedIn Profile  Susan Drexler Twitter Account  Susan Drexler News  Susan Drexler on Facebook
Chief Medical Officer
Jeffrey Dayno
  Jeffrey Dayno LinkedIn Profile  Jeffrey Dayno Twitter Account  Jeffrey Dayno News  Jeffrey Dayno on Facebook
VP - Bus. Development
Andrew Serafin
  Andrew Serafin LinkedIn Profile  Andrew Serafin Twitter Account  Andrew Serafin News  Andrew Serafin on Facebook
VP - General Counsel
Stephanie Wisdo
  Stephanie Wisdo LinkedIn Profile  Stephanie Wisdo Twitter Account  Stephanie Wisdo News  Stephanie Wisdo on Facebook


 

 

Browse more venture capital transactions:

Prev: 8/18/2020: Grafana Labs venture capital transaction
Next: 8/19/2020: Xos Trucks venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to report on every notable VC transaction. All VC database entries reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary